Cryo-Cell International Inc. CCEL

4.24 0.21 5.21% as of 25 Sep
Market cap
$32.5M
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Nov '16 Nov '17 Nov '18 Nov '19 Nov '20 Nov '21 Nov '22 Nov '23 Nov '24 Nov '25
Cash and Short Term Investments
4.12 6.72 6.92 7.45 10.45 8.34 1.72 0.98 3.50 3.30
Receivables
4.05 5.13 5.87 6.10 6.32 5.25 6.04 6.58 7.31 6.85
Inventory
0.36 0.31 1.26 1.08 0.93 0.92 0.85 0.77 0.66 0.41
Other current assets
0.08 0.21 0.25 0.26 0.24 0.71 0.43 0.51 0.45 0.63
Total current assets
9.01 12.74 14.76 15.39 18.56 15.78 9.61 9.45 12.55 11.76
Property, Plant, Equpment (Net)
0.98 0.88 1.49 1.85 1.64 3.23 13.60 21.00 21.89 21.03
Long-Term Investments
— — 0.31 0.31 0.31 0.31 0.31 0.31 — —
Goodwill and Intangible Assets (Total)
0.26 0.23 3.28 3.19 3.47 18.15 17.10 2.93 2.86 2.80
Long Term Assets (Tax, Deferred)
9.26 10.04 7.66 9.08 10.36 12.01 13.74 20.49 20.80 23.62
Long-term assets (Other)
0.03 0.03 0.11 0.43 0.50 0.57 0.65 0.75 0.82 0.92
Total non-current assets
10.53 11.17 27.63 27.50 27.64 44.88 55.28 51.77 52.12 49.97
Total Assets
19.54 23.91 42.39 42.89 46.20 60.66 64.89 61.22 64.68 61.73
Notes Payable
2.00 2.00 3.10 3.10 3.10 1.90 0.15 0.17 0.17 0.18
Accounts Payable
1.49 1.93 1.26 1.37 0.96 1.49 1.61 3.17 1.88 2.87
Accrued Expenses
2.55 2.58 2.70 2.09 2.90 3.06 3.59 5.17 5.81 4.28
Current Part of Debt
2.00 2.00 3.10 3.10 3.38 2.21 2.27 1.22 3.52 2.30
Current Revenue (Deferred)
7.07 7.43 8.37 8.88 9.18 9.36 9.59 9.70 9.79 9.73
Other current liabilities
9.18 9.65 10.74 10.78 11.12 4.96 1.98 1.20 — —
Total current liabilities
13.11 13.94 15.43 15.43 16.41 21.07 19.48 20.86 21.60 19.79
Long Term Debt (Total)
7.82 5.30 9.84 5.86 2.84 0.61 8.58 8.43 8.31 8.17
Non-current Revenue (Deferred)
12.60 15.75 20.32 23.63 27.20 31.27 36.00 41.19 46.56 50.97
Non-current Liabilities (Other)
1.43 1.43 5.71 4.92 2.38 3.52 2.04 0.92 0.92 0.92
Total non-current liabilities
21.84 22.47 35.87 34.41 32.45 35.40 46.93 51.39 56.29 60.54
Total liabilities
34.95 36.41 51.30 49.84 48.87 56.48 66.41 72.25 77.89 80.33
Additional Paid In Capital
30.34 31.37 35.52 35.92 36.58 41.59 42.60 43.41 44.27 44.71
Common Stock (Net)
0.13 0.13 0.14 0.14 0.14 0.15 0.15 0.15 0.15 0.15
Retained Earnings
(26.79) (24.47) (25.33) (22.44) (18.82) (16.74) (21.64) (31.16) (32.78) (38.44)
Treasury Stock
19.12 19.57 19.57 20.56 20.56 20.81 22.63 23.43 24.86 25.03
Common Equity (Total)
(15.41) (12.50) (8.91) (6.95) (2.67) 4.18 (1.52) (11.03) (13.22) (18.61)
Shareholders Equity (Total)
(15.41) (12.50) (8.91) (6.95) (2.67) 4.18 (1.52) (11.03) (13.22) (18.61)
Shareholders Equity and Liabilities (Total)
19.54 23.91 42.39 42.89 46.20 60.66 64.89 61.22 64.68 61.73
Shares (Common)
6.79 7.10 7.80 7.51 7.55 8.55 8.50 8.29 8.08 8.06
Shareholders Equity (Tangible)
(15.68) (12.73) (12.19) (10.14) (6.14) (13.97) (18.62) (13.96) (16.08) (21.41)
Net Debt
5.70 0.58 6.03 1.51 (4.23) (5.52) 9.13 8.67 8.33 7.17
Total Debt
9.82 7.30 12.94 8.96 6.22 2.82 10.85 9.65 11.83 10.47

Fold the line items

In millions of $ except per-share values · columns are period end dates